Binyamina, Israel

Ilan Shier

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Envue Medical Holdings, Corp., Lumenis Inc.. Active years: 2018-2026.

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2018-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Ilan Shier

Introduction

Ilan Shier is an accomplished inventor based in Binyamina, Israel. He has made significant contributions to the field of medical technology, particularly through his innovative designs and patents. His work focuses on improving treatment devices, showcasing his commitment to enhancing patient care.

Latest Patents

Ilan Shier holds a patent for a "Disposable insert for use with treatment devices." This invention reflects his dedication to creating practical solutions that streamline medical procedures and improve efficiency in healthcare settings. He has 1 patent to his name, highlighting his innovative spirit.

Career Highlights

Ilan is currently employed at Lumenis Inc., a company known for its cutting-edge medical technologies. His role at Lumenis allows him to collaborate with other talented professionals and contribute to the development of advanced treatment solutions. His expertise in the field has positioned him as a valuable asset to the company.

Collaborations

Ilan has worked closely with his coworker, Danny Koifman, to further enhance their projects and drive innovation within their team. Their collaboration exemplifies the importance of teamwork in the pursuit of groundbreaking inventions.

Conclusion

Ilan Shier's contributions to medical technology through his patent and work at Lumenis Inc. demonstrate his innovative mindset and dedication to improving healthcare solutions. His journey as an inventor continues to inspire others in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…